z-logo
open-access-imgOpen Access
Adiponectin Decreases Postprandially Following a Heat-Processed Meal in Individuals With Type 2 Diabetes
Author(s) -
Alin Stirban,
Monica Negrean,
Bernd Stratmann,
C Götting,
Julia Salomon,
K Kleesiek,
Diethelm Tschoepe
Publication year - 2007
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc07-0302
Subject(s) - medicine , adiponectin , endocrinology , postprandial , diabetes mellitus , type 2 diabetes , insulin , glycation , endothelial dysfunction , insulin resistance
Adiponectin regulates insulin sensitivity (1), reduces the expression of endothelial adhesion molecules (2), and has anti-inflammatory effects (3). Decreased adiponectin levels accompany obesity (4) and type 2 diabetes (5), promoting insulin resistance (5) and cardiovascular disease (6,7). Data on postprandial adiponectin regulation in different populations are controversial, with studies showing no effect (8–11), increases (12,13), or decreases (14,15). Advanced glycation end products (AGEs) (16) play a major role in the development of diabetes complications (17). We have shown that dietary AGEs acutely impair endothelial function (18,19), an effect counteracted by benfotiamine (20), a transketolase activator that blocks several hyperglycemia-induced pathways, including the formation of AGEs (21). AGEs might interact with adipocytes through AGE receptors (22) and induce cellular dysfunction via generation of reactive oxygen species (23), a pathway probably responsible for the AGE-induced downregulation of leptin secretion in vitro (24).Our study aimed at investigating the effects of a high heat–processed meal with high AGE content (HAGE) and a low heat–processed meal with low AGE content (LAGE) on postprandial adiponectin concentration. We postulated a protective effect of benfotiamine.Nineteen inpatients with type 2 diabetes (mean ± SEM age 55.2 ± 1.9 years; diabetes duration 7.3 ± 1.2 years; BMI 29.2 ± 0.8 kg/m2; A1C 8.8 ± 0.4%; 13 male and 6 female; 4 smokers and 15 nonsmokers; 15 on oral diabetes medication alone, 2 on oral diabetes medication plus insulin, and 2 …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom